Recombinant B7-H2 (Prezalumab Biosimilar) antibody (PE)

Catalog No. ABIN7867099

The PE-conjugated Human Monoclonal anti-B7-H2 (Prezalumab Biosimilar) antibody (ABIN7867099) specifically detects B7-H2 (Prezalumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant B7-H2 (Prezalumab Biosimilar) antibody (PE) (ABIN7867099)

Target: B7-H2 (Prezalumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This B7-H2 (Prezalumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-B7-H2 (Prezalumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-B7-H2(prezalumab biosimilar) mAb

Isotype: IgG2

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for B7-H2 (Prezalumab Biosimilar)

Target: B7-H2 (Prezalumab Biosimilar)

Alternative Name: prezalumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: ICOSLG,B7-H2,B7H2,B7RP-1,B7RP1,CD275,GL50,ICOS-L,ICOSL,LICOS,ICOS ligand,AMG557, AMG-557, MEDI-5872

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.